CXCL17 Is a Major Chemotactic Factor for Lung Macrophages

被引:44
|
作者
Burkhardt, Amanda M. [1 ,2 ]
Maravillas-Montero, Jose L. [1 ,2 ]
Carnevale, Christina D. [1 ,2 ]
Vilches-Cisneros, Natalia [3 ]
Flores, Juan P. [3 ]
Hevezi, Peter A. [1 ,2 ]
Zlotnik, Albert [1 ,2 ]
机构
[1] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA
[3] Univ Nuevo Leon, Dept Pathol Anat & Cytopathol, Monterrey 64460, Nuevo Leon, Mexico
来源
JOURNAL OF IMMUNOLOGY | 2014年 / 193卷 / 03期
基金
美国国家卫生研究院;
关键词
CHEMOKINE RECEPTOR; ALVEOLAR MACROPHAGES; MICE LACKING; GERM-FREE; LEUKOCYTE EXTRAVASATION; GENE-EXPRESSION; CELL-MIGRATION; CUTTING EDGE; PURIFICATION; ORIGIN;
D O I
10.4049/jimmunol.1400551
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokines are a superfamily of chemotactic cytokines that direct the movement of cells throughout the body under homeostatic and inflammatory conditions. The mucosal chemokine CXCL17 was the last ligand of this superfamily to be characterized. Several recent studies have provided greater insight into the basic biology of this chemokine and have implicated CXCL17 in several human diseases. We sought to better characterize CXCL17's activity in vivo. To this end, we analyzed its chemoattractant properties in vivo and characterized a Cxcl17(-/-) mouse. This mouse has a significantly reduced number of macrophages in its lungs compared with wild-type mice. In addition, we observed a concurrent increase in a new population of macrophage-like cells that are F4/80+CDllc(mid). These results indicate that CXCL17 is a novel macrophage chemoattractant that operates in mucosal tissues. Given the importance of macrophages in inflammation, these observations strongly suggest that CXCL17 is a major regulator of mucosal inflammatory responses.
引用
收藏
页码:1468 / 1474
页数:7
相关论文
共 50 条
  • [21] Intestinal guard: Human CXCL17 modulates protective response against mycotoxins and CXCL17-mimetic peptides development
    Sun, Chongjun
    Shen, Haokun
    Cai, Haiming
    Zhao, Zengjue
    Gan, Guanhua
    Feng, Saixiang
    Chu, Pinpin
    Zeng, Min
    Deng, Jinbo
    Ming, Feiping
    Ma, Miaopeng
    Jia, Junhao
    He, Rongxiao
    Cao, Ding
    Chen, Zhiyang
    Li, Jiayi
    Zhang, Linghua
    BIOCHEMICAL PHARMACOLOGY, 2021, 188
  • [22] Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye
    Enriquez-De-Salamanca, Amalia
    Dominguez-Lopez, Alfredo
    Blanco-Vazquez, Marta
    Calderon-Garcia, Andres Angel
    Garcia-Vazquez, Carmen
    Gonzalez-Garcia, Maria J.
    Calonge, Margarita
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] CXCL17 is a novel MRGPRX2 agonist: importance of cellular context
    Ding, Jie
    Fernandopulle, Nithya
    White, Carl
    Mackay, Graham
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 776 - 777
  • [24] Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma
    Hao, Jun
    Gao, Xiang
    Wang, Ya-Ping
    Liu, Qing
    Zhu, Hai
    Zhao, Shu-Jun
    Qin, Qiao-Hong
    Meng, Jie
    Li, Lin-Lin
    Lin, Shao-Chong
    Song, Zhenzhen
    Li, Hongyu
    ANTI-CANCER DRUGS, 2022, 33 (05) : 467 - 477
  • [25] Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35
    Amir, Nurul A. S. Binti Mohd
    Mackenzie, Amanda E.
    Jenkins, Laura
    Boustani, Karim
    Hillier, Marston C.
    Tsuchiya, Tomoko
    Milligan, Graeme
    Pease, James E.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (02): : 714 - 724
  • [26] CXCL17 as a prognostic biomarker for aggressive cutaneous squamous cell carcinoma.
    Fermin, Janmaris Marin
    Alam, Maksudul Md
    Gu, Xin
    Asarkar, Ameya
    Nathan, Cherie-Ann
    Khandelwal, Alok R.
    CANCER RESEARCH, 2021, 81 (13)
  • [27] Chemokines CXCL17, CCL20, and the receptor CXCR5 are overexpressed in the colonic mucosa from patients with active ulcerative colitis: CXCL17 is a potential marker of histological remission
    Yamamoto-Furusho, J.
    Iturriaga-Goyon, E.
    Fonseca-Camarillo, G.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S114 - S114
  • [28] DEMONSTRATION OF A CHEMOTACTIC FACTOR RECEPTOR ON MACROPHAGES
    SNYDERMAN, R
    FUDMAN, EJ
    JOURNAL OF IMMUNOLOGY, 1980, 124 (06): : 2754 - 2757
  • [29] CXCL17 induces activation of human mast cells via MRGPRX2
    Ding, Jie
    Hillig, Christina
    White, Carl W.
    Fernandopulle, Nithya A.
    Anderton, Holly
    Kern, Johannes S.
    Menden, Michael P.
    Mackay, Graham A.
    ALLERGY, 2024, 79 (06) : 1609 - 1612
  • [30] Markedly high salivary and lacrimal CXCL17 levels in primary Sjogren's syndrome
    Hernandez-Ruiz, Marcela
    Zlotnik, Albert
    Llorente, Luis
    Hernandez-Molina, Gabriela
    JOINT BONE SPINE, 2018, 85 (03) : 379 - 380